Simplex Trading
KYTX icon

Simplex Trading’s Kyverna Therapeutics KYTX Stock Holding History

Simplex Trading’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$180K Buy
20,900
+900
+5% +$7.5K ﹤0.01% 4421
2025
Q4 		$188K Buy
+20,000
New +$148K ﹤0.01% 4293

Other funds holding KYTX

GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return

Simplex Trading's KYTX Position: Q1 2026 in Review

Simplex Trading opened a new position in Kyverna Therapeutics (KYTX) in Q1 2026: 3,998 shares worth $34.5K. The stake represents ﹤0.01% of the portfolio and ranks #6244 among its holdings. This is a return to the name: Simplex Trading previously reported a position in KYTX as recently as Q4 2024.

Simplex Trading first reported a position in KYTX in Q4 2024 and has held it in 2 quarters since. 111 funds tracked by Wall St. Rank hold KYTX as of Q1 2026.

  • Simplex Trading held 3,998 shares of Kyverna Therapeutics worth $34.5K as of Q1 2026.
  • Kyverna Therapeutics was a new Simplex Trading position in Q1 2026.
  • Kyverna Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6244 holding.
  • Simplex Trading first reported a position in Kyverna Therapeutics in Q4 2024 and has held it in 2 quarters since.
  • 111 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.